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Abstract
Background: The measurement of gene expression using microarray technology is a complicated
process in which a large number of factors can be varied. Due to the lack of standard calibration
samples such as are used in traditional chemical analysis it may be a problem to evaluate whether
changes done to the microarray procedure actually improve the identification of truly differentially
expressed genes. The purpose of the present work is to report the optimization of several steps
in the microarray process both in laboratory practices and in data processing using criteria that do
not rely on external standards.
Results: We performed a cDNA microarry experiment including RNA from samples with high
expected differential gene expression termed "high contrasts" (rat cell lines AR42J and NRK52E)
compared to self-self hybridization, and optimized a pipeline to maximize the number of genes
found to be differentially expressed in the "high contrasts" RNA samples by estimating the false
discovery rate (FDR) using a null distribution obtained from the self-self experiment. The proposed
high-contrast versus self-self method (HCSSM) requires only four microarrays per evaluation. The
effects of blocking reagent dose, filtering, and background corrections methodologies were
investigated. In our experiments a dose of 250 ng LNA (locked nucleic acid) dT blocker, no
background correction and weight based filtering gave the largest number of differentially
expressed genes. The choice of background correction method had a stronger impact on the
estimated number of differentially expressed genes than the choice of filtering method. Cross
platform microarray (Illumina) analysis was used to validate that the increase in the number of
differentially expressed genes found by HCSSM was real.
Conclusion: The results show that HCSSM can be a useful and simple approach to optimize
microarray procedures without including external standards. Our optimizing method is highly
applicable to both long oligo-probe microarrays which have become commonly used for well
characterized organisms such as man, mouse and rat, as well as to cDNA microarrays which are
still of importance for organisms with incomplete genome sequence information such as many
bacteria, plants and fish.
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Background
Gene-expression microarrays are widely used for large
scale studies in cells, and are emerging as promising tools
in clinical diagnosis, with potential impact on the assess-
ment of prognosis and choice of treatment [1]. Microarray
data are also increasingly becoming essential for data
driven model building in system biology approaches
[2,3]. However, the measurement of gene expression
using e.g. cDNA microarray technology is a complex proc-
ess that involves several steps, which have not yet been
fully optimized. In a typical cDNA microarray experiment,
total RNA from two biological sources in which gene
expression levels are to be compared, is labelled with two
different fluorescent dyes and hybridized to an array of
spotted cDNA probes. After hybridization and scanning
the data are further pre-processed. This often includes
image analysis, filtering of data and background subtrac-
tion before normalization and transformation of data.
Relative gene expression levels are given as ratios of inten-
sities of fluorescent emission from labelled the RNAs'.
Many different approaches and methods can be used at
each stage of a microarray experiment, and there is still no
definitive consensus about which methods to choose
(reviewed and discussed in [4]).
Sample quality, labeling protocol, hybridization condi-
tions, scanning protocols and image acquisition as well as
the different stages in the microarray data analysis pipe-
line can all contribute to the overall uncertainty of the
conclusions drawn. There has therefore recently been an
emerging focus on the need for universally applicable
standards, reference materials and analytic guidelines to
assist in the standardization of microarray experiments [4-
10]. In order to choose or optimize microarray methods
several criteria can be used. The use of external RNA spike-
in controls is the most recommended approach for tech-
nology assessment and optimization. However, the rec-
ommended use of spike-in RNA might not always be
feasible. For optimal application several controls and
probes must be used and the spike-in controls must be
representative of the endogenous RNA with respect to e.g.
length, sequence characteristics, melting temperature and
cross-hybridization risk [7]. On some arrays suitable
spike-in controls are not printed, and printing a sufficient
number of spikes can leave insufficient room for the genes
of biological interest. Other valuable tools are calibrated
reference RNA samples such as those developed in the
MAQC project [10] or mixed tissue RNA samples devel-
oped by Thompson et al. [11,12]. However, it is not
always possible to have RNA samples with known differ-
ences in the expression level of many genes from the spe-
cies of interest.
One general strategy that can be used is to minimize the
variability of self-self hybridizations [13]. Unfortunately,
this criterion focuses on the zero ratios that are the least
interesting biologically and will tend to minimize varia-
bility (noise) as well as signal, which may not improve the
overall ability to detect differentially expressed genes. One
major concern is that the optimization criterion should
increase the chances of discovering truly differentially
expressed genes. Here we propose an optimization
method that requires only four microarrays per evaluation
and uses both hybridizations of RNA from samples with
marked differences in gene expression, termed "high con-
trasts" as well as self-self hybridizations. A change in
either laboratory procedure or data processing can
increase real signal or just increase the noise. If the noise
is increased this will also affect the self-self hybridizations.
On the other hand, if signal is lost and genes are pushed
artificially towards zero ratios, this will shrink ratios in the
high contrast experiments. In the high contrast versus self-
self method (HCSSM) proposed here we maximize the
difference between a self-self and a high contrast experi-
ment. This difference is quantified as the number of sig-
nificantly differentially expressed genes in the high
contrast experiment at a certain false discovery rate (FDR)
estimated using the self-self experiments as a null distribu-
tion. Genes are scored for differential expression on the
basis of the high contrast and the self-self hybridization
separately using a modified T- statistic [14].
Where   is the estimated effect for gene g,   is the mod-
ified gene variance and νg is the inverse of the number of
degrees of freedom for gene g. A T-score threshold is cho-
sen, and the FDR is the ratio between the number of genes
above the cut-off on the self-self list and high contrast list.
To find genes at a specific false discovery rate (e.g. 0.05),
T-scores computed for the high contrast and the self-self
experiment are sorted and the T-score cut-off is lowered
until the chosen false discovery rate is obtained (Figure 1).
The number of genes found at a standard false discovery
rate (e.g. 5 %) may then be used as an optimization crite-
rion to be maximized. It is important to note that this
method of determining FDR rates relies on a large number
of truly differentially expressed genes in the high contrast
experiment and should not be used as a tool for analysis
of biological experiments where only a few genes may be
differentially expressed.
Applications
There is a large number of steps in the microarray produc-
tion, hybridization, scanning and data analysis that have
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adjustable parameters that may be optimized. We will
show how HCSSM can be used to optimize data analysis
and hybridization protocols. As mentioned above, the
standard microarray data analysis pipeline consists of
image analysis, filtering of data, background correction,
normalization and identification of differentially
expressed genes. Recent studies have focused on the nor-
malization step and evaluated a large number of normal-
ization methods for cDNA microarray data [15,16]. We
have therefore chosen to test the HCSSM on filtering and
background correction, as these are fields where there is
still considerable debate in the literature [4,17].
Effects of level of filtration on the number of differentially expressed 
genes
It is common in microarray analysis to reduce the impact
of spots that are malformed or have intensities outside the
linear range of the scanner. Such spots are either removed,
or weighted down using some measure of spot quality.
Filtering has been shown to introduce bias in microarray
studies [18], but has also been shown to significantly
reduce variation in self-self hybridizations [13]. However,
as far as we know, no work has shown how the bias versus
variance  trade-off in practice influences the ability to
detect differentially expressed genes. Therefore, we tested
a number of different filtering methods of increasing com-
plexity to evaluate how they influence the ability to find
differentially expressed genes in a study.
Often filtering consists of removing spots with intensities
below a (arbitrary) threshold [19]. We have however
found no investigations into the effect of such filtering.
Several filtering methods based on spot quality statistics
have been reported [13,18,20]. These quality measures
can be used as filters by setting a spot quality threshold,
but can also be used as weights to reduce the impact of
low quality spots.
We propose a simple quality measure using the variability
information available from most image analysis software.
The variation in a log ratio (SM) can be approximated
from the variation in the pixel intensities using Equation
(2) [19]
Where G and R are the green and red signal intensities, σR,
σG are the pixel standard deviations in the red and green
channel respectively.
Quality weighting can be obtained by:
The delta term is a small number added to stabilize spots
with very small uncertainties.
Effects of background correction on the number of differentially 
expressed genes
The rationale of background correction is that the e.g.
observed green signal intensity (G) is a linear combina-
tion of a true signal coming from the labelled RNA (Gt)
and a background signal (Gb) so that:
G = Gt + G b (4)
More accurate log ratios can then be obtained by correct-
ing the observed signal by subtracting the background.
The problem then is to correctly estimate the background
signal for each spot in the image analysis phase, and cor-
recting this estimate to satisfy prior criteria e.g. back-
ground smoothness and non-negativity of the true signal.
Background correction in itself may also destabilize
results by increasing variance [5], and may decrease the
ability to detect differentially expressed genes. Therefore,
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The High Contrast versus Self-Self method (HCSSM) Figure 1
The High Contrast versus Self-Self method (HCSSM). 
The figure illustrates how the false discovery rate is deter-
mined in HCSSM. For a chosen T cut-off, the genes with T-
scores larger than the cut-off are declared significant. The 
false discovery rate is then determined by dividing the 
number of genes deemed significant in the self-self experi-
ment by the number of genes deemed significant in the high 
contrast experiment. For example, if for a T-cut-off six genes 
are declared significant from the self-self experiment and 127 
genes are declared significant from the high contrast experi-
ment the false discovery rate will be 6/127 ~0.05. If a specific 
false discovery rate is wanted (often 0.05 or 0.01), the T cut-
off can be adjusted to obtain it.
Differentially
expressed
genes T Cut-off
THC TSS
False positives Differentially
expressed
genes T Cut-off
THC TSS
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we use the HCSSM to compare the ability to find differen-
tially expressed genes when no background correction is
used versus a non negative background correction method
[21].
Effect of choice and dose of dT blockers in cDNA microarray 
experiments
The HCSS-method can be applied to the laboratory proce-
dures as well as to the data processing steps in microarray
research. One major source of bias in cDNA microarrays is
cross-hybridization of the labelled RNA to non-target
homologous probe sequences on the array [22-24]. A sub-
stantial proportion of the non-specific cross-hybridiza-
tion signal is due to poly(dA)-poly(dT) cross
hybridization since poly(dT)-containing molecules pro-
duced during labelling of poly(dA) tails of sample RNAs
by reverse transcription can bind promiscuously to the
poly(dA) stretch of cDNA probe spots. These poly(dA)
hybridization signals reduce the ability to detect differen-
tially expressed genes. Thus, minimization of poly(dA)
hybridization is a major challenge in cDNA microarray
experiments. To reduce the poly(dA) signals it is common
practice to add a blocker like synthetic poly(dA) in the
probe or poly(dT) in the hybridization mixture [25-27].
Recently, an LNA dT Blocker containing Locked Nucleic
Acid (LNA) nucleotides [28] has been introduced. There is
currently no standardized protocol available that can be
used to evaluate and optimize blocking procedures with
respect to optimizing the observed number of differen-
tially expressed genes. In the present study we therefore
compared the effect of poly(dA)40–60 and different doses
of LNA dT blocker on the number of differentially
expressed genes, and used the HCSSM to optimize identi-
fication of truly differentially expressed genes.
Results and discussion
The choice and dose of blocking reagent influences the 
number of differentially expressed genes estimated
In order to evaluate how different conditions designed to
block poly(dA)-poly(dT) cross hybridization affect the
ability to detect differentially expressed genes, we applied
the HCSS-method to analysis of microarray experiments
performed in the presence of either poly(dA)40–60 or vary-
ing amounts of LNA. Poly(dA)40–60 binds to the poly(dT)
segment of the labelled target in the hybridization solu-
tion and thus competes with the poly(dA) segment in the
microarray cDNA probes. LNA dT blocker contains
Locked Nucleic Acid (LNA) nucleotides [28] at key posi-
tions within the (dT) synthetic strand, and is designed to
block poly (dA) sequences present in the microarray
cDNA probes and prevent them from hybridizing to
poly(dT) segment of the labelled targets.
Six different blocking conditions with dye-swap and self
versus self were investigated in a total of 24 hybridizations
(Figure 2). Significantly differentially expressed genes
were determined by estimating the false discovery rate
using a null distribution obtained from the self-self exper-
iments, as described in the Background section. Filtration
was performed as described below and in the Methods
section. Our results clearly demonstrate the effect of
blocking the poly(dT) segment of the labelled target since
addition of poly(dA)40–60 increased the number of esti-
mated differentially expressed genes from 167 (no poly
dA/dT blocking reagent) to 588. The LNA dT blocker fur-
ther increased the number of estimated differentially
expressed genes in a dose dependent manner with a max-
imum of 2064 differentially expressed genes estimated in
the presence of 250 ng LNA (Figure 3). In general, more
than five biological experiments are recommended for
detecting differentially expressed genes in microarry
experiments [4]. Technical replicates are mainly recom-
mended in quality-control studies. We would like to
emphasize that even our HCSS-method only requires four
microarrays per evaluation; more experiments are needed
to accurately determine whether the spike in differentially
expressed genes for the 250 ng LNA polyA is a real opti-
mum or noise in the dose response curve. It is also impor-
tant to notice that the optimal dose and choice of blocker
may vary for different arrays and microarray protocols.
However, our results indicate that the concept of using
self-self and high contrast hybridizations in control exper-
iments is well suited to identify optimal blocking condi-
tions.
Graphical representation of experimental design of the  microarray experiment Figure 2
Graphical representation of experimental design of 
the microarray experiment. The nodes correspond to 
RNA from samples with high expected differential gene 
expression (rat cell lines NRK52E and AR42J) compared to 
self-self hybridization (rat cell line AR42J). The samples were 
hybridized to rat 15 k cDNA duplicates under six different 
blocking conditions including no blocker, 1000 ng poly(dA)40–
60, and 25 to 1000 ng LNA dT blocker. Dye-swap and self ver-
sus self were performed for all blocking conditions (total of 
24 hybridizations). Green-labelled samples are placed at the 
tail and red labelled samples at the head of the arrows.
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Background correction method has a stronger impact on 
the estimated number of differentially expressed genes 
than filtering
The data from the blocking study were also analysed using
combinations of filter methods and background correc-
tion (Figure 4 and Additional file 1). We tested the follow-
ing five different filtering methods of increasing
complexity: coarse, medium, fine, uncertain and weighting
filter. Filters were based on spot foreground intensity, per-
centage of pixels saturated and ratio uncertainties as
described in the Methods section. In addition we applied
three different background corrections: none  were only
foreground signal is used to calculate ratios, Edwards
which is a subtraction method that ensures positive values
[21] and dampened Edwards were a small number is added
to the corrected signal to avoid extreme ratios in those
cases where the background corrected intensities would
be very low. Weight based filtering; using the ratio uncer-
tainty to reduce the impact of "bad" spots without remov-
ing them completely found the highest numbers of
differentially expressed genes regardless of background
correction method and blocking agent dose (Figure 4 and
Addition file 1). The choice of background correction
method had a higher impact on the number of differen-
tially expressed genes than filtering. No background correc-
tion resulted in the highest amount of differentially
expressed genes estimated, the numbers ranging from 515
to 2064 under the five different filtering methods and
blocking with 250 ng LNA (Figure 4). Edwards and damp-
ened Edwards gave 66–120 and 191–588 differentially
expressed genes, respectively, under the same filtering
conditions. Our results strongly indicate that omission of
background correction consistently improves the results.
The reason may be that background correction introduces
a lot of variability to remove a small bias. As long as the
red and green backgrounds are highly correlated they will
dampen the ratios, but only significantly for the low
intensity spots, for which the ratios are uncertain anyway.
One strategy may be to use error propagation to evaluate
background correction, and only background correct the
spots where the bias is large, thus not increasing the vari-
ance of all spots, but still removing the bias for some of
the worst affected spots.
Validation of cDNA microarray data generated by HCSSM
In our experiments a dose of 250 ng LNA dT blocker gave
the highest number of differentially expressed genes.
When HCSSM was further used to evaluate steps in the
computational analysis of microarray data we found that
no background correction and weight based filtering estimated
2064 differentially expressed genes (gene list A in Figure
5) compared to 588 when the data was analysed by damp-
ened Edwards background correction and weight based filter-
ing (gene list B in Figure 5). Thus, omission of background
correction added ~1478 unique genes to the list of genes
identified as differentially expressed. Only 2 of the 588
genes identified with dampened Edwards background correc-
tion and weight based filtering were not detected when no
background correction was performed (Figure 5).
In order to investigate the level of concordance of biolog-
ical themes represented in the gene lists A and B, we used
GeneTools, an "all in one" annotation web tool package
Effects of background correction and level of filtration on the  number of differentially expressed genes estimated Figure 4
Effects of background correction and level of filtra-
tion on the number of differentially expressed genes 
estimated. The figure shows data from hybridization with 
250 ng LNA blocker added.
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Effect of choice and dose of dT blocker on the number of dif- ferentially expressed genes Figure 3
Effect of choice and dose of dT blocker on the 
number of differentially expressed genes. The figure 
shows data analysed with weighted filtration and no background 
correction (see Methods section).
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[29] recently described by Beisvag et al, 2006 [30]. The
two gene lists (reporter lists) were submitted to eGOn
(explore genontology), which automatically associates
Gene Ontology (GO) terms from public databases to the
submitted gene list. We found that the main GO terms
were represented in both gene list A and gene list B. Fur-
thermore, the proportion (number of genes in A/number
of genes in B) associated with specific GO terms was sim-
ilar for all terms, as illustrated for selected GO terms in
Table 1. The average proportion for all GO terms associ-
ated with five or more genes was 2.9 ± 0.8, n = 64 (Addi-
tional file 2). This indicated that the increase in differently
expressed genes estimated by HCSSM was not random.
We than applied cross platform analysis to validate that
the 1478 genes added to the gene list was real.
Cross platform microarray analysis
The combined use of multiple microarray platforms has
recently been suggested as an alternative that is comple-
mentary to qRT-PCR for validation of gene expression
profiles [31-33]. In an attempt to validate a large fraction
of the cDNA microarray results we used the Illumina Gene
Expression system (San Diego, CA) for cross-platform
analysis of differentially expressed genes in AR42J cells
versus NRK52E cells. The same sources of total RNA used
in the cDNA microarray experiments were hybridized to
Illumina's Sentrix® RatRef-12 Expression BeadChips, with
six technical replicates for each cell line as described in the
Methods section. Only genes common to both platforms
were included in the analysis. Of the 1478 additional
genes identified with no background correction, 553 genes
were represented on both the spotted cDNA arrays and the
Illumina RatRef-12 Expression BeadChips. Of these 553
genes, 398 (72 %) were identified as differentially
expressed in the same direction (higher versus lower) on
both platforms (Fig 6). The overlaps of differentially
expressed genes across commercially microarray plat-
forms are recently reported to be~80–90 % [10,32,33].
Since RT-PCR is still considered the "golden standard" for
gene expression measurements, we further used SYBR
green-based quantitative real-time PCR to validate the rel-
ative gene expression for a few of the 1478 additional
genes identified with optimal conditions. Commonly, a 2
Table 1: Selected GO categories associated with genes differentially expressed in the cell lines AR42J versus NRK52E.
GO number GO term A B AUB BÚA AÚB Proportion
GO:0008150 biological process 724 233 233 491 0 3.1
GO:0008152 metabolic process 459 135 135 324 0 3.4
GO:0032502 developmental process 246 91 91 155 0 2.7
GO:0007154 cell communication 202 69 69 133 0 2.9
GO:0050896 response to stimulus 165 64 64 101 0 2.6
GO:0048468 cell development 112 38 38 74 0 2.9
GO:0006950 response to stress 101 32 32 69 0 3.2
GO:0009056 catabolic process 65 30 30 35 0 2.2
GO:0007049 cell cycle 60 13 13 47 0 4.6
GO:0016265 death 60 18 18 42 0 3.3
GO:0006928 cell motility 51 17 17 34 0 3.0
GO:0040007 growth 42 19 19 23 0 2.2
GO:0006952 defence response 32 7 7 25 0 4.6
GO:0019725 cell homeostasis 30 12 12 18 0 2.5
A: Gene list generated with no background correction and weight based filtering. B: Gene list generated with dampened Edwards background correction 
and weight based filtering. AUB: number of genes differentially expressed in both gene list A and B. AÚB: number of genes differentially expressed 
in gene list A but not in gene list B. BÚA: number of genes differentially expressed in gene list B but not in gene list A. Proportion: number of 
genes in A/number of genes in B. The genes were annotated using GeneTools [30] according to UniGen build #163. All GO categories associated 
with more than five genes are shown in Additional file 2.
Comparison of gene lists generated with different back- ground correction methods Figure 5
Comparison of gene lists generated with different 
background correction methods. The left figure illus-
trates the number of differentially expressed genes estimated 
with no background correction (A) and dampened Edwards back-
ground correction (B). The Venn diagram shows overlap of dif-
ferentially expressed genes estimated with no background 
correction (blue) and dampened Edwards (grey). All data are 
from hybridization with 250 ng LNA blocker added and 
weight based filtering.
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fold change is reported as the cut-off below which micro-
array and qRT-PCR data begin to loose correlation,
although recent reports observed significant correlation
where genes exhibited 1.4 fold change or higher [34,35].
We therefore selected seven genes in the fold ratio range
4.8 to 1.8 (log2 ratio range 2.2 to 0.9 on the cDNA arrays).
Results are shown in Additional files 3 and 4. Description
of PCR primers and qRT-PCR protocol are shown in Addi-
tional file 5. Five of the selected genes (Ica1, c-fos, Btg2,
Uhrf and Ube2b) were detected as differentially expressed
on both microarray platforms. Two genes (Hoxa2b and
Irfrd) were only identified on the the cDNA platform. Five
genes with fold ratio > 2 were verified by qRT-PCR (see
Additional files 3 and 4). Two genes (Hoxa2 and Ube2b)
with fold ratio < 2 were not verified. Hox2b was excluded
from the results due to technical problems (see Additional
file 4). The gene Ube2b  was expressed in the opposite
direction relative to the cDNA microarray, but in the same
direction as on the Illumina platform (higher in AR42J
than in NRK52E on Illumina, lower on cDNA). Consist-
ent with other reports [35,36], the microarray ratios were
compressed compared to qRT-PCR results (see Additional
file 3). Overall, the qRT-PCR measurement corresponded
100 % (5/5) with the Illumina data and 71 % (5/7) with
the cDNA microarray data. The latter confirmation rate is
in accordance with cDNA microarray results of others
([37], and references therein).
Some of the discrepancy between cDNA microarry versus
Illumina and qRT-PCR may be due to errors (reported by
e.g. [38]) in the IMAGE collection used for probes in our
cDNA microarrays. We thus consider the results from qRT-
PCR and the Illumina platform more likely to be "true
data" in the present study. In spite of the known errors on
cDNA platforms, cross platform analysis confirmed 72 %
of the results. Validation of a few selected genes by qRT-
PCR supported this finding. Taken together, functional
annotation analysis and the alternative methods for vali-
dation of the cDNA micoarry data indicated that the
increase in the number of differentially expressed genes
found by HCSSM was mainly real.
Conclusion
In the present study we have used the HCSSM in cDNA
microarray control experiments to evaluate blocking con-
ditions, filtration and background correction. We found
that the choice and dose of poly(dT)-poly(dA) blocking
agents during hybridization influenced the estimated
number of differentially expressed genes. When HCSSM
was used to evaluate steps in the computational analysis
of microarray data we found that no background correction
and weight based filtering gave the largest estimated num-
bers of differentially expressed genes. The background cor-
rection method, however, has a stronger impact on the
numbers of differentially expressed genes found than fil-
tering. The results show that HCSSM may be a useful and
simple approach to optimize cDNA microarrays proce-
dures without including external standards.
Methods
Cells
AR42J (rat pancreatic acinar cell derived, ATCC, Rockville,
MD) were grown in Dulbecco's modified Eagle's medium
(DMEM) with 4.5 g/l glucose (Invitrogen, Carlsbad, CA),
15 % fetal calf serum (Euroclone Ltd, Devon, UK), 1 mM
sodium pyruvate, 0.1 mg/ml L-glutamine (Invitrogen,
Carlsbad, CA), 10 U/ml penicillin/streptomycin (Invitro-
gen, Carlsbad, CA), and 1 µg/ml fungizone (Invitrogen
Carlsbad, CA). NRK52E cells (rat kidney epithelial cells,
ATCC, Rockville, MD) were grown in DMEM with 4.5 g/l
glucose (Invitrogen, Carlsbad, CA) supplemented with 5
% FCS (Euroclone Ltd), 0.1 mg/ml L-glutamine (Invitro-
gen, Carlsbad, CA) and 10 U/ml penicillin/streptomycin
(Invitrogen, Carlsbad, CA). All cells were grown at 37°C
in a humidified atmosphere at 5 % CO2.
Cross platform microarray analysis Figure 6
Cross platform microarray analysis. The figure shows 
ratios (log2 based) from 553 genes comparable between the 
cDNA and the Illumina platforms. Red dots: genes signifi-
cantly up-regulated on the Illumina platform. Green dots: 
genes significantly down-regulated on the Illumina platform. 
Black dots: genes not identified as significantly different 
between the cell lines (AR42J versus NRK52E) on the Illumina 
platform. All the genes were identified as differentially 
expressed on the cDNA platform, and the concordance 
between cDNA and Illumia is 72 %.
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Treatment of cells and isolation of RNA
AR42J and NRK52E cells were cultured in 75 cm2 culture
flasks for 72 h until confluence was reached. Total RNA
was isolated using RNeasy® Midi kit (Qiagen, German-
town, MD) according to the manufacturer's instruction.
RNA was quantified and assessed for purity by measure-
ment of OD260 and OD280 using a UV fiberoptic spec-
trophotometer (Nanodrop Technologies, Rockland, DE)
and was qualitatively assessed by measurement of relative
28S and 18S ribosomal band intensities using a Bioana-
lyzer and RNA LabChip capillary gel electrophoresis assay
(Agilent Technologies, Palo Alto, CA). Aliquots were kept
frozen at -80°C until further processing.
cDNA Microarray procedure
cDNA Microarrays were manufactured by the Norwegian
Microarray Consortium [39] using 15000 cDNA rat
probes from Research Genetics (IMAGE collection)
printed in duplicates on Corning CMT Gaps II slides
(Corning Inc. NY). The probes were dissolved in 50 %
DMSO to ensure high printing quality. The microarray
slides were UV cross linked at 300 mJ in order to fix the
DNA to the glass slides.
Labelling was performed by reverse transcription of total
RNA from the cell lines (3 µg each) in the presence of
primers containing the capture sequence for subsequent
hybridization of Cy3- and Cy5-labelled dendrimers, using
the Genisphere 3DNA Array 350 Expression Array Detec-
tion kit (Genisphere, Hatfield, PA) as described in the
manufacturer's protocol. Different combinations of
blocking reagents were added to the hybridization mix-
ture: Mouse COT-1 DNA (Life Technologies) was added
to all mixtures (0.1 µg/µg RNA) in order to block hybrid-
ization of repetitive elements. Different concentrations
(0.1–4.0  µl = 25–1000 ng) of LNA dT Blocker (Geni-
sphere, Hatfield, PA) and 1 µl = 1000 ng Poly(dA)40–60
(Stratagen Spotreporter; La Jolla, CA) were used as illus-
trated in Figure 2.
Hybridization was done in a humidified hybridization
chamber (Corning Inc., NY) at 60°C for 14–15 h in a total
hybridization volume of 60 µl. Post hybridization washes
were done for 15 min at 55°C with 2× SSC and 0.2 % SDS,
for 10 min at room temperature with 2× SSC, and finally
for 10 min at room temperature with 0.2× SSC. After the
washing, the Cy3- and Cy5-labelled dendrimers were
hybridized to the capture sequence at the reverse tran-
scribed sample RNA at 60°C for 3 h as described in the
manufacturer's protocol. After dendrimer hybridization,
the slides were washed as described above and dried by
centrifugation at 1500 rpm for 5 min.
Scanning and image analysis of cDNA microarrays
The slides were scanned at a resolution of 10 µm by use of
Packard Bioscience Scanarray Express HT scanner (Pack-
ard BioScience, Billerica, MA). A laser power of 100 % was
used, and excitation of Cy3 and Cy5 was performed at a
wavelength of 532 nm and 635 nm, respectively. Signals
were detected by use of photomultiplier tubes (PMTs)
with two channels. In order to maximizing the certainty of
the weakest spots, the PMT voltage was adjusted to keep
the background intensity between 200 and 400 (mean
spot intensity) in each channel as suggested in [40]. The
GenePix 5.0 image analysis software (Axon Instruments,
Inc., Union City, CA) was used for spot segmentation and
intensity calculations. Spots and regions with high unspe-
cific binding of dye or dust particles were manually
flagged and excluded from the analysis.
Data analysis of cDNA microarrays
Modified T-scores and false discovery rate (FDR) values
were calculated as described under Applications in the
Background section for all combinations of filter, back-
ground corrections, and blocking treatments.
Filtering methods
A progression of increasingly complex filter functions was
evaluated.
Coarse filter: Spots flagged as bad or missing during the
image analysis are removed.
Medium filter: Also removes spots with intensities below
200 and spots with more than 70 % saturation in both
channels.
Fine filter: Also removes spots that are small, i.e. spots with
diameters less than 20.
Uncertain filter: Removes spots flagged by GenePix 5.0 as
"bad" or "missing" and spots with deltaM > 3.
Weight based filter: Quality weighting can be obtained by
using Equation (3) as described in the Background sec-
tion:
The delta term is a small number added to stabilize spots
with very small uncertainties.
Background correction methods
Three different background corrections strategies were
applied:None were only foreground signal is used to calcu-
late ratios, Edwards which is a subtraction method that
ensures positive values [21] and dampened Edwards were a
w
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small number (e.g. 20) is added to the corrected signal to
avoid extreme ratios in those cases where the background
corrected intensity would be very low.
Statistical analysis
After filtering and background correction, all arrays were
normalized using loess to remove intensity dependent
variations in the ratios [41]. Differentially expressed genes
were found at the 5 % FDR level using the methodology
described in the Background section.
Cross-platform microarray analysis
The Illumina Gene Expression system was used for cross-
platform analysis of differentially expressed genes in
AR42J cells versus NRK52E cells. RNA amplifications and
hybridization were performed at the Finnish DNA Micro-
array Centre at Turku Centre of Biotechnology [42].
Briefly, aliquots from the same RNA as in the cDNA
microarray experiments were amplified with Ambion's
Illumina®  TotalPrep RNA Amplification kit (cat no
AMIL1791) using 400 ng of total RNA as input material.
The in vitro transcription (IVT) amplification that incor-
porated biotin-labelled nucleotides was performed over-
night (14 h) at 37°C. After the amplifications the cRNA
concentrations where checked with NanoDrop ND-1000
and cRNA quality was controlled by BioRad's Experion
electrophoresis station.
A total of 750 ng of each biotin-labelled cRNA sample was
hybridized to Illumina's Sentrix® RaRef-12-v1 Expression
BeadChips at 58°C overnight (17 h) according to the
manufacturer's instructions. The hybridized biotinylated
cRNA was detected with 1 µg/ml Cyanine3-streptavidine,
(GE Healthcare Biosciences; cat no PA43001) and the
Beadchips were scanned with Illumina BeadArray Reader
(Factor = 1, PMT = 521, Filter = 100 %). Numerical results
were extracted with Bead Studio v3.0.19.0 without any
normalization or background subtraction.
The Illumina data were analysed using a modified T-test
[14] with p-values adjusted for false discovery rate [43],
and genes with adjusted p-values < 0.05 were taken as sig-
nificant. Entrez Gene IDs were used as common identifi-
ers for the microarray platforms. The genes were identified
according to UniGen build #163 in GeneTools [29,30].
Database submission of microarray data
The microarray data were prepared according to mini-
mum information about a microarray experiment
(MIAME) recommendations [44] and deposited in the
Array Express [45]. Detailed information about the micro-
array designs (platforms) and raw data files from the
experiments are accessible in ArrayExpress by use of these
accession numbers; A-MEXP-358  (cDNA platform), E-
TABM-202  (cDNA experiment) and E-TABM-307  (Illu-
mina experiment).
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